Background: Cystic brain radionecrosis (CBRN) is a late-onset devastating complication after radiotherapy for head and neck neoplasms, especially for nasopharyngeal carcinoma (NPC). To our knowledge, it has scarcely been reported. Methods: We retrospectively reviewed all available medical records of NPC patients with CBRN who were treated with surgical intervention. Results: Sixteen patients were identified in this study and the mean latency of CBRN was 9.2 ± 0.9 years. The total irradiation dose of the nasopharynx ranged from 60 to 78 Gy. Cyst-like lesions were observed and there were slightly enhancements on the cyst wall in five patients on patients' brain MRI. All the included patients underwent surgical resection of the cystic necrotic lesion thought temporal approach. Specimens from surgery revealed reactive gliosis and immunopositive cytokines including TNF-α, IL-6 and HIF-2α. Only one patient experienced recurrence and received reoperation after surgery. All the other patients made a good recovery and no operationrelated mortality was observed. Conclusions: CBRN is a delayed but irreversible neurological sequel in irradiated NPC patients. Post-radiotherapy follow-up is quite necessary for those with high risk of CBRN. Proper treatment is needed for early CBRN patients to suppress inflammation in the brain. Timely neurosurgery may benefit patients with late-stage CBRN by alleviating increased intracranial pressure and inflammatory responses.
Introduction
Nasopharyngeal carcinoma (NPC) is one of the most prevalent head and neck malignancies in Southern China (1) . In Guangdong Province, the incidence rate of NPC is more than 20 per 100,000 person-years among males in specific endemic areas, making it the most common type of cancer in this province and known as 'Canton tumor' (2) (3) (4) .
Radiotherapy is a mainstay treatment for NPC owing to its radiosensitivity and special pathological features (5) . However, radiotherapy may lead to severe side effects considering that normal brain tissue adjacent to the nasopharyngeal cavity is inevitably exposed to the irradiation, particularly the temporal lobes. Moreover, with improvements in treatments, NPC patients are able to have long survival times (6, 7) . Along this prolonged lifetime, irradiated NPC patients are at risk of developing late-onset radiation-induced brain injury, especially to the bilateral inferior temporal lobes (8) .
Despite the fact that cystic brain radionecrosis (CBRN) is an uncommon late-onset complication in irradiated patients with NPC, it is likely to be life-threatening with developing brain necrosis and increasing intracranial pressure (9) . To date, no effective treatments have consistently been proven to reverse or halt the pathologic process of CBRN since the underlying mechanisms remain to be delineated (10) . A few reports have previously documented cystic formation in irradiated NPC patients, yet CBRN has seldom been thoroughly investigated (5, 11, 12) .
For further study, we analyzed the clinical data obtained from NPC patients who suffered from CBRN after radiotherapy and underwent neurosurgery in our hospital. This study may provide a new direction for further research on effective therapeutic strategies for CBRN.
Patients and methods
This study was approved by the ethics committee of Sun Yat-sen University. Written informed consents were obtained from all involved patients.
We retrospectively reviewed the clinical profiles of irradiated NPC patients, who developed CBRN after radiotherapy for NPC and accepted surgical resection of the cyst(s) in our hospital from January 2011 to May 2016. All available data were collected from eligible patients for the investigation of CBRN, including age at surgery, gender, latency period, pathological classification, tumor stage, total dose of irradiation, side of surgery, follow-up period, first symptoms, image features, pathologic findings and clinical outcomes. Montreal Cognitive Assessment (MoCA) was performed to assess the cognitive function of patients. Descriptive statistics were used to analyze these clinical records and data were shown as mean ± standard error (SE).
Diagnosis and treatment of CBRN
The diagnosis of CBRN was based on clinical characteristics, imaging features and pathological manifestations, excluding other diseases such as recurrence of tumor and abscess. Drugs were initially administrated for the treatment of CBRN. However, when the cystic brain necrosis became unrelenting and life-threatening owing to developing intracranial pressure, patients received surgical resection of the necrotic lesions.
Follow up
These series of postoperative patients were periodically followed up by certified neurologists according to a typical follow-up schedule, consisting of outpatient clinic visits or telephone interviews at 3 postoperative months, 6 months, 1 year and then yearly or as needed.
Results
From January 2011 to May 2016, there were 462 NPC patients who developed various brain radiation-associated complications after undergoing radiotherapy at Sun Yat-sen Memorial Hospital of Sun Yat-sen University. Through this review, we indentified 16 patients (3.46%, age, 31-68 years; mean, 48.9 years), who suffered from CBRN. The characteristics of included patients are presented in Table 1 .
Clinical characteristics of patients with NPC
All patients had a history of pathologically confirmed NPC. According to the 2002 tumor, node and metastasis classification system of the American Joint Committee on Cancer (AJCC), there were two patients having stage T1, six having stage T2, five having stage T3 and three having stage T4 NPC. Nodal involvement was N1 in eight patients, N2 in six patients and N3 in two patients, and all the cases were free of distant metastases. The pathological subtypes included 11 keratinizing squamous cell carcinomas (KSCC), one differentiated non-keratinizing carcinoma (D-NKC) and four undifferentiated non-keratinizing carcinomas (UD-NKC).
Patients were treated with conventional two-dimensional radiotherapy (2-DRT), after being diagnosed with NPC. The conventional external beam radiotherapy was comprised of a three-field facial technique surrounding the nasopharynx and immediate risk areas, as well as a single matched anterior split neck field. The initial irradiation doses ranged from 60 to 78 Gy (mean 69.5 ± 1.2 Gy). Treatment was completed in 1.8-2.0 Gy fractions daily five times per week. Of these patients, 10 with advanced stage T3-T4 or N2-N3 NPC received concurrent chemotherapy.
After treatment, patients were periodically evaluated at 6-month intervals and no one experienced recurrence of NPC.
Clinical characteristics of patients with CBRN
The mean latency between radiotherapy and CBRN was 9.2 years, encompassing a large time span from 4 to 17 years, and the male-tofemale ratio was 7:1 as shown in Table 1 . The clinical manifestations of CBRN were mainly related to increased intracranial pressures, including dizziness (n = 10, 62.5%), headache (n = 8, 50.0%), impaired memory (n = 7, 43.8%), weakness (n = 5, 31.3%), secondary seizures (n = 3, 18.8%), drowsiness (n = 2, 12.5%), and impaired vision (n = 1, 6.3%).
Brain MRI features
Brain magnetic resonance images (MRI) scanning is an important examination for irradiated NPC patients. All included cases had received brain MRI scanning regularly at 6-month or 1-year intervals after undergoing radiotherapy for NPC. Obvious cystic formation in the brain could appear in patients' MR images when irradiated NPC patients had developed CBRN. The cyst-like lesions could be indicated by a hypo-intense signal on T 1 weighted images (T 1 WI), a hyper-intense signal on T 2 weighted images (T 2 WI), and a hyper-intense signal on T 2 -weighted FLAIR sequences (Figs 1A-D and 2A-D). Furthermore, there was slightly contrast enhancement on cyst wall in unilateral or bilateral cerebral hemispheres of five patients. Multiple cystic cavitations could be seen in four patients. Moderate to severe white matter edema surrounding the cyst-like lesions was demonstrated by high T 2 -weighted signal in all patients. On follow-up brain MRI, cysts increased gradually in size, resulting in developing mass effect.
Pathologic outcomes
Pathologic results revealed that specimens from surgery mainly consisted of cavities with extensive necrosis, reactive gliosis, central liquefaction, telangiectasia, neuronal degeneration, hyalinized blood vessel walls and calcium deposits. There was no evidence of malignancy ( Figs 1E and F, 3A and B) .
Interestingly, we found that the expression of tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), and hypoxia-inducible factor-2α (HIF-2α) was noted in reactive astrocytes, which were identified by the glial fibrillary acidic protein (GFAP), in the cystic necrotic lesion of Case 8 ( Fig. 3C-F) . In contrast, the expression of vascular endothelial growth factor (VEGF) and cytokeratin (CK) was negative.
Treatment and prognosis
In our study, all patients were initially medicated with drugs to alleviate clinical disorders, including glucocorticoids, mannitol, gangliosides, nerve growth factors, anticoagulants, etc. Unfortunately, despite all these active measures, cystic lesions developed progressively and eventually enlarged in size. In order to relieve the growing intracranial pressure, they all received neurosurgical resection of the cystic necrotic lesions and cyst wall after aspiration of cystic fluid, mainly through the temporal approach. All resection margins were clear and the removal was strictly limited to the cystic necrotic tissues. One patient experienced recurrence of CBRN in the other The side for operation when both sides had cyst formation. cerebral hemisphere and received reoperation at 17.5 months after surgery.
All the other patients made a good recovery after treatment with open craniotomy and the mean postoperative follow-up period was 29.8 months, ranging from 6 to 56 months. There was no operationrelated mortality and no complication-related mortality in our series of patients. Among the sixteen patients, eight of ten patients were free from dizziness and eight were free from headache. MoCA scores of seven patients with preoperative impaired memory were improved. No seizure was observed in the three patients with preoperative epilepsy. Two patients were free from drowsiness, while weakness was improved in 4 of 5 patients. The patient with preoperative impaired vision was not improved after surgery (Table 2) .
Discussion
It is reported that the incidence of cerebral radiation-induced necrosis in irradiated NPC patients was~5% in 10 years with a mean latency period of 5 years after radiotherapy. Unfortunately, little is known about the incidence of CBRN in irradiated NPC patients recently. According to a previous report (9) , the occurrence of cystic brain necrosis was about one-tenth of those having cerebral radiation-induced necrosis. Although rare, an increasing number of patients suffered from late-onset radiation-induced complications including CBRN, a catastrophic neurological injury and mainly responsible for radiation-related deaths in irradiated NPC patients. Therefore, CBRN has successfully grabbed the attention of both the clinical professionals and the researchers.
In this study, we investigated the clinical data of 16 cases with CBRN, including the clinical characteristics, MRI features, histological results and treatment. The clinical characteristics of CBRN were generally related to the mass effect due to the cyst formation.
MRI scanning, a sensitive noninvasive examination, plays an important role in discovering cyst formation and monitoring disease progression. In the beginning of CBRN, edema of white matter usually appears, and cystic lesions emerge subsequently with or without boundary enhancement. Cystic lesions can enlarge progressively in size and as a result, the cystic necrotic lesions inevitably develop with obvious mass effect. When NPC patients appear cyst-like lesions after radiotherapy, clinical doctors need to be aware of it and distinguish CBRN from brain abscess and tumors. Both CBRN and abscess can present as ring-enhancing cystic lesions but irradiated NPC patients with cerebral abscess generally have a history of infection or steroid administration (13) .
The characteristics of computed tomography (CT) images of CBRN were previously described by Lee et al. (14) . CT scanning may show cyst-like shadows with or without contrast enhancement. Considering the better tissue resolution of MRI than CT scanning, when CT images show cyst-like shadows in irradiated NPC patients, it is better for patients to undergo MRI scanning for further examination. Particularly, it should be noted that, imaging findings could be inconsistent with clinical manifestations. Patients with typical CBRN features on MRI may not present any clinical symptoms. Therefore, regular follow-up with a brain MRI scanning is pretty necessary for irradiated NPC patients with high risk of CBRN.
To date, the pathogenesis of CBRN is poorly clarified. Theories on pathophysiology of CBRN mainly include the following groups: vascular damage, glial injury, neuronal dysfunction, enzymatic disturbance and inflammatory responses. These underlying mechanisms usually coexist in the chronic development of CBRN.
One popular theory postulated that the microcirculation disorders and the blood brain barrier loss, induced by vascular endothelial cell damage, could allow inflammatory cells to infiltrate into the extravascular space. Their subsequent secretion of cytokines could promote further immune responses, resulting in a circle of uncontrolled inflammation (15) . Consistent with this theory, we found that cytokines including TNF-α, IL-6 and HIF-2α, were immunopositive in astrocytes but negative in vascular tissue in Case 8. The role of TNF-α in blood brain barrier damage had been well established and IL-6 appeared to contribute to both tissue necrosis and neovascularization in adjacent to the necrotic core (16) . Besides, the hypoxic condition existing in the perinecrotic lesions may initiate production of angiogenetic factors in activated astrocytes through upregulation of HIF-2α (17) . It is reported that VEGF temporally and spatially contributed to the enlargement of radionecrosis. However, it was negative in our selected patient, maybe owing to the improper site of specimen. Additionally, we found that there were high levels of protein and white blood cell counts in patients' cystic fluid, indicating that boosts in some biomolecules could promote the etiopathology of radiation injury. Thus, we speculated that the main source of cytokines in CBRN was a dynamic cascade of marginal reactive astrocytes, not endothelial cells, which may offer potential insights into the pathogenesis of CBRN and identify a new direction in better therapeutic strategy for CBRN.
The mean latency interval of our series of patients was consistent with previous literature (9) . However, why did the progression occur early after radiation in some cases? It may be probably associated with ionizing radiation, radiosensitivity of individuals, total radiation dose and the administration of biotherapeutics. Ionizing radiation is thought to induce vascular endothelial cell damage through bystander effect of genomic instability (16, 18) . Since the radiosensitivity of endothelial cells differs among the innumerable blood vessels, the development of radionecrosis varies individually. Individual radiosensitivity and megadose radiation may bring patients a higher risk of extensive endothelial cell damage. It is found by Lee et al. that NPC patients with a schedule of 4.2 Gy per fraction had a higher occurrence of radiation-induced necrosis than those with 2.5 Gy (19) . Antibody-based biotherapeutics may also accelerate the enlargement of the necrosis due to related immunosuppression and subsequent impaired cellular response to damaged tissue (20, 21) . All of these above factors increase the risk of developing CBRN.
For patients with late-stage CBRN, conservative therapy has been proved to be futile, though steroid therapy can temporarily achieve symptomatic relief in early stage (12) . For those with significant mass effect in brain and typical symptoms of CBRN, timely neurological intervention is usually warranted to reduce their mortality. In fact, there are various methods including aspiration of the cystic fluid, surgical resection of the cysts, drainage of the cysts through cystoperitoneal shuntin, etc. (22) (23) (24) . These methods are favorable for promptly decreasing intracranial pressure. However, the complete removal of cystic necrotic lesions is likely to attenuate the necrosis progression and disrupt the vicious circle of inflammatory responses (25) .
Conclusions
Taken together, medical professionals should make more efforts to apply effective radiotherapy with less toxicity to normal organs, better tumor coverage and long-term survivals for NPC patients. To patients 
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